Code Pharma B.V. Integration-Promoting Peptides, EP3841108A1, April 2026
Summary
The European Patent Office published patent application EP3841108A1 for pharmaceutical compositions comprising integration-promoting peptides, filed by Code Pharma B.V. The application, published April 15, 2026, covers Designated States including all major European jurisdictions. Competitors developing similar peptide-based therapeutics should monitor this application during the standard publication window.
“PHARMACEUTICAL COMPOSITIONS COMPRISING INTEGRATION-PROMOTING PEPTIDES”
About this source
GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 46 changes logged to date.
What changed
The EPO published patent application EP3841108A1 for pharmaceutical compositions comprising integration-promoting peptides, filed by Code Pharma B.V. with inventors Esmira Naftali and Zyon Ayni. The application carries IPC classification C07K 7/08 and covers 30 Designated States including AT, BE, DE, ES, FR, GB, IT, NL, and others.
This publication represents a new intellectual property filing rather than a granted patent — competitors developing similar integration-promoting peptide therapeutics should monitor the application during the standard publication window to assess potential freedom-to-operate implications. No binding obligations are imposed on third parties at this publication stage.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
PHARMACEUTICAL COMPOSITIONS COMPRISING INTEGRATION-PROMOTING PEPTIDES
Publication EP3841108A1 Kind: A1 Apr 15, 2026
Applicants
Code Pharma B.V.
Inventors
NAFTALI, Esmira, AYNI, Zyon
IPC Classifications
C07K 7/08 20060101AFI20220323BHEP A61P 31/18 20060101ALI20220323BHEP A61K 9/00 20060101ALI20220323BHEP A61K 47/10 20170101ALI20220323BHEP A61K 47/26 20060101ALI20220323BHEP C12N 9/12 20060101ALI20220323BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.